Table 3.

Multivariate regression analysis assessing the effectiveness of tolvaptan

Variable	OR (95% CI)	P-value
Reduction of urine osmolality (mOsm/l)	1.007 (1.004–1.014)	0.040*
UICC stage	0.341 (0.120–0.967)	0.043*
UICC T-factor	0.332 (0.108–1.022)	0.055*

P-values <0.05 were considered statistically significant.

CI, confidence interval; OR, odds ratio; UICC, Union for International Cancer Control.